(Brooklyn Neustater/ CTV News) — Researchers at the University of Oxford in England are trialling a potential breakthrough vaccine for HIV that they hope could also serve as a cure for infected individuals.
The clinical trial, known as HIV-CORE 0052, will test the HIVconsvX vaccine. University of Oxford professor Tomas Hanke says the vaccine is a “mosaic,” capable of targeting a range of HIV-1 variants.
He told CTV’s Your Morning on Tuesday that if successful, the trial could open up the possibility that this single vaccine could be used across the globe. (…)